Bär & Karrer Successfully Represented Respondent in Setting-Aside Proceedings before the Swiss Fede
Bär & Karrer successfully represented a Turkish construction company against the State of Libya in setting-aside proceedings before the Swiss Federal Supreme Court in connection with an ICC award issued in an investment treaty arbitration. The underlying claims arose out of construction projects commissioned by the State of Libya.
Bär & Karrer Advises Castik Capital on the Sale of Acrotec Group
Castik Capital entered into a share purchase agreement with Carlyle Group regarding the sale of the Acrotec Group. Acrotec Group is an independent supplier of watch components for the Swiss luxury mechanical watch market, a main player in the European MedTech components market and a supplier of high precision components for various end markets such …
Continue reading “Bär & Karrer Advises Castik Capital on the Sale of Acrotec Group”
Bär & Karrer Advised the forteq Group on the Sale of forteq Nidau to Liberta Partners
Bär & Karrer advised the forteq Group, a global supplier of complex plastic components, on the sale of the forteq Nidau AG (healthcare business) to Liberta Partners, Munich. The forteq Group will focus on its core activities in the automotive industry.
Bär & Karrer Advises EMZ Partners on the Acquisition of a Majority Stake in Assepro
EMZ Partners, a European Private Equity company, has agreed to acquire a majority stake in Assepro, a leading independent insurance broker group with a focus on small and medium-sized enterprises in Switzerland covering a broad value chain including brokerage, insurance advisory, risk management, pension schemes, financial/pension planning and employee benefits.
Bär & Karrer Advises Valora on its Share Placement
Valora Holding AG completed a placement of shares by way of an accelerated bookbuilding process raising net proceeds of approximately CHF 70 million. Credit Suisse and UBS acted as Joint Bookrunners.
Bär & Karrer Advises the Managers in CHF 18.6 Million Rights Offering of Kuros Biosciences.
On 23 October 2020, Kuros Biosciences, a life science company focusing on the development and marketing of orthobiologics, completed a capital increase by way of a rights offering to its shareholders. 50.2% of the shareholders of Kuros Biosciences exercised their subscription rights in the rights offering. The remaining 4,192,530 offered shares were placed in the …
Bär & Karrer Advised Credit Suisse, J.P. Morgan and BofA Securities in the Rights Offering of Idors
On 23 October 2020, Idorsia Ltd completed a capital increase by way of an at-market rights offering. The offer price was set at CHF 22.50 per share and the capital increase resulted in gross proceeds of approximately CHF 535.5 Million. Idorsia intends to use the net proceeds of approximately CHF 520 Million to support the …
Bär & Karrer Advised Syngenta on its Acquisition of a Production Facility from Novartis
Syngenta Crop Protection AG, a global leading chemical crop protection company, acquired a production facility located on the GETEC PARK.SWISS area from Novartis Pharma Schweizerhalle AG.
Bär & Karrer Advised OLX on its Cooperation with Encuentra24
OLX Group, a leading global marketplaces network, and Encuentra24, a leading marketplace and business solution provider in Central America, merged their business activities in Central America under the Encuentra24 brand.
Bär & Karrer Advises BancaStato on the Acquisition of Ticino-based Retail Business Lines from EFG I
Banca dello Stato del Canton Ticino (BancaStato) has agreed with EFG International to acquire its Ticino-based retail business lines, with around CHF 1.2 billion of client assets. The two parties are also committed to exploring further areas of collaboration in Ticino in the future. The operation, which is meant to enable both parties to focus …